How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Abstract: Complicated deformation problems are frequently encountered in medical image registration tasks. Although various advanced registration models have been proposed, accurate and efficient ...
An exercise-driven course on Advanced Python Programming that was battle-tested several hundred times on the corporate-training circuit for more than a decade. Written by David Beazley, author of the ...
Abstract: We consider the problem of computing the inverse dynamics of a serial robot manipulator with N elastic joints in a recursive numerical way. The solution algorithm is a generalized version of ...
PyCaret 4.0 is a ground-up architectural revamp. The 3.x line is frozen on PyPI as pycaret 3.4.0 — no further commits. Track progress in docs/revamp/STATUS.md and ...
Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results